| 注册
首页|期刊导航|肿瘤防治研究|硼中子俘获治疗现状及发展方向

硼中子俘获治疗现状及发展方向

马佳 柏预立 韩光

肿瘤防治研究2026,Vol.53Issue(4):243-250,8.
肿瘤防治研究2026,Vol.53Issue(4):243-250,8.DOI:10.3971/j.issn.1000-8578.2026.25.0967

硼中子俘获治疗现状及发展方向

Current Status and Future Development of Boron Neutron Capture Therapy

马佳 1柏预立 1韩光1

作者信息

  • 1. 430079 武汉,华中科技大学同济医学院附属湖北肿瘤医院放射治疗中心
  • 折叠

摘要

Abstract

Boron neutron capture therapy(BNCT)is a precision radiotherapy technology for tumors.On the international stage,Japan stands out as a representative country where BNCT has progressed into a mature clinical phase.Although China started relatively late,it has achieved rapid advancements through independent research and development in accelerator and neutron source equipment,domestically produced boron drugs,and clinically validated therapeutic efficacy.In several key indicators,China has now reached internationally advanced levels.Looking ahead,efforts should be prioritized toward the development of third-generation boron-based drugs,the standardization of treatment protocols,and cost reduction to enhance treatment accessibility,ultimately aiming to build a competitive BNCT clinical application and technological innovation system.

关键词

硼中子俘获治疗/临床现状/研究进展

Key words

Boron neutron capture therapy/Clinical treatment status/Research development

分类

医药卫生

引用本文复制引用

马佳,柏预立,韩光..硼中子俘获治疗现状及发展方向[J].肿瘤防治研究,2026,53(4):243-250,8.

基金项目

Talent Project of Hubei Cancer Hospital(No.2025HBCHQHRC011) 湖北省肿瘤医院启航人才项目(2025HB-CHQHRC011) (No.2025HBCHQHRC011)

肿瘤防治研究

1000-8578

访问量0
|
下载量0
段落导航相关论文